Mark A. Glaire

2.2k total citations
15 papers, 593 citations indexed

About

Mark A. Glaire is a scholar working on Oncology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Mark A. Glaire has authored 15 papers receiving a total of 593 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Pathology and Forensic Medicine and 5 papers in Molecular Biology. Recurrent topics in Mark A. Glaire's work include Cancer Immunotherapy and Biomarkers (7 papers), Genetic factors in colorectal cancer (6 papers) and Cancer Genomics and Diagnostics (3 papers). Mark A. Glaire is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Genetic factors in colorectal cancer (6 papers) and Cancer Genomics and Diagnostics (3 papers). Mark A. Glaire collaborates with scholars based in United Kingdom, Netherlands and Norway. Mark A. Glaire's co-authors include Neil Ryan, Emma J. Crosbie, David N. Church, D. Gareth Evans, Tjalling Bosse, Emad El‐Omar, Roland Arnold, Fenne L. Komdeur, Annechien Plat and Arjan Kol and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Clinical Cancer Research.

In The Last Decade

Mark A. Glaire

15 papers receiving 590 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark A. Glaire United Kingdom	10	320	156	153	152	144	15	593
Lucia Musacchio Italy	15	283 0.9×	63 0.4×	93 0.6×	151 1.0×	96 0.7×	46	551
Luke Freeman-Mills United Kingdom	7	197 0.6×	137 0.9×	75 0.5×	175 1.2×	109 0.8×	7	492
Dominique Berton France	11	365 1.1×	90 0.6×	89 0.6×	78 0.5×	54 0.4×	35	481
Lindsey E. Minion United States	8	170 0.5×	70 0.4×	46 0.3×	142 0.9×	90 0.6×	15	438
Stefan Kommoss Germany	6	147 0.5×	191 1.2×	53 0.3×	155 1.0×	191 1.3×	10	718
Charles R. Boice United States	10	137 0.4×	85 0.5×	67 0.4×	191 1.3×	120 0.8×	12	648
Peter Schlosshauer United States	12	110 0.3×	74 0.5×	53 0.3×	270 1.8×	53 0.4×	20	568
Louise De Brot Brazil	17	174 0.5×	68 0.4×	28 0.2×	138 0.9×	68 0.5×	52	585
Simone Punt Netherlands	11	455 1.4×	46 0.3×	404 2.6×	152 1.0×	101 0.7×	14	733
Sho Sato Japan	12	157 0.5×	20 0.1×	101 0.7×	117 0.8×	81 0.6×	32	411

Countries citing papers authored by Mark A. Glaire

Since Specialization

Citations

This map shows the geographic impact of Mark A. Glaire's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Glaire with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Glaire more than expected).

Fields of papers citing papers by Mark A. Glaire

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Glaire. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Glaire. The network helps show where Mark A. Glaire may publish in the future.

Co-authorship network of co-authors of Mark A. Glaire

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Glaire. A scholar is included among the top collaborators of Mark A. Glaire based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Glaire. Mark A. Glaire is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Ryan, Neil, Mark A. Glaire, Natalja T. ter Haar, et al.. (2024). Patterns of cytotoxic T-cell densities in immunogenic endometrial cancers reveal a potential mechanism for differences in immunotherapy efficacy. SHILAP Revista de lepidopterología. 3(1). e000320–e000320. 1 indexed citations

Glaire, Mark A., Neil Ryan, Marieke E. Ijsselsteijn, et al.. (2022). Discordant prognosis of mismatch repair deficiency in colorectal and endometrial cancer reflects variation in antitumour immune response and immune escape. The Journal of Pathology. 257(3). 340–351. 16 indexed citations

Jiang, Dan, Tarjei S. Hveem, Mark A. Glaire, et al.. (2021). Automated assessment of CD8+ T-lymphocytes and stroma fractions complement conventional staging of colorectal cancer. EBioMedicine. 71. 103547–103547. 7 indexed citations

Ryan, Neil, James M. Bolton, Natalja T. ter Haar, et al.. (2021). Histological and Somatic Mutational Profiles of Mismatch Repair Deficient Endometrial Tumours of Different Aetiologies. Cancers. 13(18). 4538–4538. 9 indexed citations

Workel, Hagma H., Joyce M. Lubbers, Roland Arnold, et al.. (2019). A Transcriptionally Distinct CXCL13+CD103+CD8+ T-cell Population Is Associated with B-cell Recruitment and Neoantigen Load in Human Cancer. Cancer Immunology Research. 7(5). 784–796. 167 indexed citations

Ryan, Neil, et al.. (2019). The proportion of endometrial cancers associated with Lynch syndrome: a systematic review of the literature and meta-analysis. Genetics in Medicine. 21(10). 2167–2180. 135 indexed citations

Glaire, Mark A., Enric Domingo, Anita Sveen, et al.. (2019). Tumour-infiltrating CD8+ lymphocytes and colorectal cancer recurrence by tumour and nodal stage. British Journal of Cancer. 121(6). 474–482. 39 indexed citations

Jonge, Marthe M. de, Aurélie Auguste, Lise M. van Wijk, et al.. (2018). Frequent Homologous Recombination Deficiency in High-grade Endometrial Carcinomas. Clinical Cancer Research. 25(3). 1087–1097. 119 indexed citations

Ryan, Neil, et al.. (2018). The prevalence of Lynch syndrome in women with endometrial cancer: a systematic review protocol. Systematic Reviews. 7(1). 121–121. 10 indexed citations

10.

Glaire, Mark A., Enric Domingo, George Nicholson, et al.. (2018). Tumour-infiltrating CD8⁺ lymphocytes as a prognostic marker in colorectal cancer: A retrospective, pooled analysis of the QUASAR2 and VICTOR trials.. Journal of Clinical Oncology. 36(15_suppl). 3515–3515. 4 indexed citations

11.

Glaire, Mark A., Enric Domingo, Louis Vermeulen, et al.. (2016). POLE proofreading domain mutation defines a subset of immunogenic colorectal cancers with excellent prognosis. Annals of Oncology. 27. vi152–vi152. 6 indexed citations

12.

Gemmell, Matthew, Susan A. Berry, Mark A. Glaire, et al.. (2016). Extending colonic mucosal microbiome analysis—assessment of colonic lavage as a proxy for endoscopic colonic biopsies. Microbiome. 4(1). 61–61. 46 indexed citations

13.

Glaire, Mark A., Matthew Brown, David N. Church, & Ian Tomlinson. (2016). Cancer predisposition syndromes: lessons for truly precision medicine. The Journal of Pathology. 241(2). 226–235. 14 indexed citations

14.

Glaire, Mark A., et al.. (2014). MicroRNAs in gastrointestinal malignancy. European Journal of Cancer Prevention. 23(6). 540–549. 4 indexed citations

15.

Glaire, Mark A., Emad El‐Omar, Timothy C. Wang, & Daniel L. Worthley. (2012). The mesenchyme in malignancy: A partner in the initiation, progression and dissemination of cancer. Pharmacology & Therapeutics. 136(2). 131–141. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact